Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Tobacco smoking induces metabolic reprogramming of renal cell carcinoma
James Reigle, … , Jarek Meller, Maria F. Czyzyk-Krzeska
James Reigle, … , Jarek Meller, Maria F. Czyzyk-Krzeska
Published September 24, 2020
Citation Information: J Clin Invest. 2021;131(1):e140522. https://doi.org/10.1172/JCI140522.
View: Text | PDF
Clinical Research and Public Health Metabolism Oncology Article has an altmetric score of 67

Tobacco smoking induces metabolic reprogramming of renal cell carcinoma

  • Text
  • PDF
Abstract

BACKGROUND Clear cell renal cell carcinoma (ccRCC) is the most common histologically defined renal cancer. However, it is not a uniform disease and includes several genetic subtypes with different prognoses. ccRCC is also characterized by distinctive metabolic reprogramming. Tobacco smoking (TS) is an established risk factor for ccRCC, with unknown effects on tumor pathobiology.METHODS We investigated the landscape of ccRCCs and paired normal kidney tissues using integrated transcriptomic, metabolomic, and metallomic approaches in a cohort of white males who were long-term current smokers (LTS) or were never smokers (NS).RESULTS All 3 Omics domains consistently identified a distinct metabolic subtype of ccRCCs in LTS, characterized by activation of oxidative phosphorylation (OXPHOS) coupled with reprogramming of the malate-aspartate shuttle and metabolism of aspartate, glutamate, glutamine, and histidine. Cadmium, copper, and inorganic arsenic accumulated in LTS tumors, showing redistribution among intracellular pools, including relocation of copper into the cytochrome c oxidase complex. A gene expression signature based on the LTS metabolic subtype provided prognostic stratification of The Cancer Genome Atlas ccRCC tumors that was independent of genomic alterations.CONCLUSION The work identified the TS-related metabolic subtype of ccRCC with vulnerabilities that can be exploited for precision medicine approaches targeting metabolic pathways. The results provided rationale for the development of metabolic biomarkers with diagnostic and prognostic applications using evaluation of OXPHOS status. The metallomic analysis revealed the role of disrupted metal homeostasis in ccRCC, highlighting the importance of studying effects of metals from e-cigarettes and environmental exposures.FUNDING Department of Defense, Veteran Administration, NIH, ACS, and University of Cincinnati Cancer Institute.

Authors

James Reigle, Dina Secic, Jacek Biesiada, Collin Wetzel, Behrouz Shamsaei, Johnson Chu, Yuanwei Zang, Xiang Zhang, Nicholas J. Talbot, Megan E. Bischoff, Yongzhen Zhang, Charuhas V. Thakar, Krishnanath Gaitonde, Abhinav Sidana, Hai Bui, John T. Cunningham, Qing Zhang, Laura S. Schmidt, W. Marston Linehan, Mario Medvedovic, David R. Plas, Julio A. Landero Figueroa, Jarek Meller, Maria F. Czyzyk-Krzeska

×

Total citations by year

Year: 2024 2023 2022 2021 Total
Citations: 2 3 2 3 10
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (10)

Title and authors Publication Year
Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
Zheng B, Liu K, Ouyang Q, Feng J, Cao S, Wang L, Jia T, Wu S, Ma X, Zhang X, Li X
Clinical and Translational Medicine 2024
Copper Drives Remodeling of Metabolic State and Progression of Clear Cell Renal Cell Carcinoma
Bischoff ME, Shamsaei B, Yang J, Secic D, Vemuri B, Reisz JA, D\u2019Alessandro A, Bartolacci C, Adamczak R, Schmidt L, Wang J, Martines A, Venkat J, Tcheuyap VT, Biesiada J, Behrmann CA, Vest KE, Brugarolas J, Scaglioni PP, Plas DR, Patra KC, Gulati S, Landero Figueroa JA, Meller J, Cunningham JT, Czyzyk-Krzeska MF
Cancer Discovery 2024
Modulation of oxidative phosphorylation and mitochondrial biogenesis by cigarette smoke influence the response to immune therapy in NSCLC patients
Wang Y, Smith M, Ruiz J, Liu Y, Kucera GL, Topaloglu U, Chan MD, Li W, Su J, Xing F
Lung cancer (Amsterdam, Netherlands) 2023
Microtubule-associated protein MAP1LC3C regulates lysosomal exocytosis and induces zinc reprogramming in renal cancer cells.
Verma R, Aggarwal P, Bischoff ME, Reigle J, Secic D, Wetzel C, VandenHeuvel K, Biesiada J, Ehmer B, Landero Figueroa JA, Plas DR, Medvedovic M, Meller J, Czyzyk-Krzeska MF
The Journal of biological chemistry 2023
Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
Tang C, Xie AX, Liu M, Kuo F, Kim M, Di Natale R, Golkaram M, Chen Y, Gupta S, Motzer R, Russo P, Coleman J, Carlo MI, Voss MH, Kotecha RR, Han Lee C, Tansey W, Schultz N, Hakimi AA, Reznik E
Cell Metabolism 2023
A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.
Shen Y, Huang Q, Zhang Y, Hsueh CY, Zhou L
Cancer Cell International 2022
Sarcomatoid renal cell carcinoma with clear cells and eosinophilia: a case report and short review of the literature
Neşiu A, Neamţu C, Nicolescu CM, Totolici BD, Mureşanu HD, Roşu MC, Ardelean A, Silivestru VC, Stăniş LA, Marţi TD
Romanian Journal of Morphology and Embryology 2022
Metabolic subtypes of clear cell renal cell carcinoma defined by tobacco smoking
MF Czyzyk-Krzeska, J Meller, JA Figueroa, DR Plas, JT Cunningham
Molecular & Cellular Oncology 2021
Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
MF Czyzyk-Krzeska, JA Figueroa, S Gulati, JT Cunningham, J Meller, B ShamsaeI, B Vemuri, DR Plas
Genes & development 2021
Biomarkers in renal cell carcinoma: Are we there yet?
S Gulati, NJ Vogelzang
Asian Journal of Urology 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 7 news outlets
Blogged by 1
Posted by 20 X users
47 readers on Mendeley
See more details